Project Oncology®
Showcasing major breakthroughs in cancer care from worldwide clinical trials, Project Oncology® educates and assists the healthcare professionals who dedicate their lives to helping patients fight cancer.
Here you’ll find leading oncologists discuss and share essential cancer care strategies for all different types of cancer. And as worldwide clinical trials continue to explore new screening tests and discover novel treatment options, you can rest assured that you’ll always catch the latest in cancer research with Project Oncology®.
- Update frequency
- every 5 days
- Episodes
- 347
- Years Active
- 2015 - 2025
The Impact of Advocacy on Healthcare
If we want to ensure that we and our patients have healthcare when we’re older and it continues to be available, it’s important to take a stand and be a part of…
Managing B-Cell Lymphomas in the Second-Line Setting: The Role of CAR T-Cell Therapy
Guest: Sarah Rutherford, MD
Due to its strong response rates and manageable adverse events, CAR T-cell therapy is now considered the standard-of-care treatment…
Maximizing B-Cell Lymphoma Outcomes with CAR T-Cell Therapy and Personalized Care
Guest: Tara Graff, DO, MS
The therapeutic landscape for relapsed or refractory B-cell lymphoma has greatly evolved in the past several years, wi…
Managing B-Cell Lymphomas in the Second-Line Setting: The Role of CAR T-Cell Therapy
Guest: Sarah Rutherford, MD
Due to its strong response rates and manageable adverse events, CAR T-cell therapy is now considered the standard-of-care treatment…
Maximizing B-Cell Lymphoma Outcomes with CAR T-Cell Therapy and Personalized Care
Guest: Tara Graff, DO, MS
The therapeutic landscape for relapsed or refractory B-cell lymphoma has greatly evolved in the past several years, wi…
Treating mCRPC with Lutetium-177 and Radium-223: Expert Insights
Lutetium-177and radium-223 have both been shown to significantly improve survival in patients with metastatic castration-resistant prostate cancer, but how do these tr…
Treating mCRPC with Lutetium-177 and Radium-223: Expert Insights
Lutetium-177and radium-223 have both been shown to significantly improve survival in patients with metastatic castration-resistant prostate cancer, but how do these tr…
mCRPC Care: Reducing Progression Risk by Combining Enzalutamide and Talazoparib
Guest: Neeraj Agarwal, MD, FASCO
TALAPRO-2 was a recent phase 3 study conducted in the first-line metastatic castration-resistant prostate cance…
mCRPC Care: Reducing Progression Risk by Combining Enzalutamide and Talazoparib
Guest: Neeraj Agarwal, MD, FASCO
TALAPRO-2 was a recent phase 3 study conducted in the first-line metastatic castration-resistant prostate cance…
Prostate Cancer Research: Why Disparities Exist in Mortality and Trial Access
A recent study sought to investigate why there are disparities in mortality as well as access and participation in clinical trials among vulnerable prostate cancer pop…
Prostate Cancer Research: Why Disparities Exist in Mortality and Trial Access
A recent study sought to investigate why there are disparities in mortality as well as access and participation in clinical trials among vulnerable prostate cancer pop…
Novel Immune Checkpoint Strategies in Non-Small Cell Lung Cancer Care
Guest: Aakesh Desai, MD, MPH
According to research featured at the 2023 ASCO Annual Meeting, novel immune checkpoint targets have the potential to inform drug deve…
Prostate Cancer Care: Improving Hormonal Therapy Sequencing Post-Treatment Intensification
If hormonal therapies are not working for prostate cancer patients, chemotherapy may be a reliable alternative based on findings from a recent study. In fact,…
Novel Immune Checkpoint Strategies in Non-Small Cell Lung Cancer Care
Guest: Aakesh Desai, MD, MPH
According to research featured at the 2023 ASCO Annual Meeting, novel immune checkpoint targets have the potential to inform drug deve…
Prostate Cancer Care: Improving Hormonal Therapy Sequencing Post-Treatment Intensification
If hormonal therapies are not working for prostate cancer patients, chemotherapy may be a reliable alternative based on findings from a recent study. In fact,…
The Necessity of a Multidisciplinary Approach Through the mCRPC Treatment Journey
For patients who start out with hormone sensitive prostate cancer, there's a period of time where the prostate cancer cells are responsive to suppressing …
The Necessity of a Multidisciplinary Approach Through the mCRPC Treatment Journey
For patients who start out with hormone sensitive prostate cancer, there's a period of time where the prostate cancer cells are responsive to suppressing …
Prostate Cancer Care: Overcoming Challenges in Delivering Germline Testing to Veterans
Between patient anxiety and insurance implications, there are several challenges associated with delivering germline testing to veterans with advanced prostate cancer.…
ASCO GU 2024: Reviewing Updated Practice Guidelines for Prostate Cancer
The National Comprehensive Cancer Network (NCCN) has recommended new guidelines for the treatment of prostate Cancer. In this episode, you’ll learn about …
Prostate Cancer Care: Overcoming Challenges in Delivering Germline Testing to Veterans
Between patient anxiety and insurance implications, there are several challenges associated with delivering germline testing to veterans with advanced prostate cancer.…